Showing 1 - 5 results of 5 for search '"cardiac disease"', query time: 0.12s Refine Results
  1. 1

    Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. by Piechnik, S, Ferreira, V, Dall'Armellina, E, Cochlin, L, Greiser, A, Neubauer, S, Robson, M

    Published 2010
    “…BACKGROUND: T1 mapping allows direct in-vivo quantitation of microscopic changes in the myocardium, providing new diagnostic insights into cardiac disease. Existing methods require long breath holds that are demanding for many cardiac patients. …”
    Journal article
  2. 2

    Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. by Ferreira, V, Piechnik, S, Robson, M, Neubauer, S, Karamitsos, T

    Published 2014
    “…Its unsurpassed accuracy in defining cardiac morphology and function and its ability to provide tissue characterization make it well suited for the study of patients with cardiac diseases. Late gadolinium enhancement was a major advancement in the development of tissue characterization techniques, allowing the unique ability of CMR to differentiate ischemic heart disease from nonischemic cardiomyopathies. …”
    Journal article
  3. 3

    Myocardial tissue characterization by magnetic resonance imaging: Novel applications of T1 and T2 mapping by Ferreira, V, Piechnik, S, Robson, M, Neubauer, S, Karamitsos, T

    Published 2014
    “…Its unsurpassed accuracy in defining cardiac morphology and function and its ability to provide tissue characterization make it well suited for the study of patients with cardiac diseases. Late gadolinium enhancement was a major advancement in the development of tissue characterization techniques, allowing the unique ability of CMR to differentiate ischemic heart disease from nonischemic cardiomyopathies. …”
    Conference item
  4. 4

    T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. by White, S, Sado, D, Fontana, M, Banypersad, S, Maestrini, V, Flett, A, Piechnik, S, Robson, M, Hausenloy, D, Sheikh, A, Hawkins, P, Moon, J

    Published 2013
    “…ECV >0.4 = 0.040 ± 0.075, p < 0.001).Bolus only, T1 mapping-derived ECV measurement is sufficient for ECV measurement across a range of cardiac diseases, and this approach is histologically validated in AS. …”
    Journal article
  5. 5

    T1 mapping for myocardial extracellular volume measurement by CMR: Bolus only versus primed infusion technique by White, S, Sado, D, Fontana, M, Banypersad, S, Maestrini, V, Flett, A, Piechnik, S, Robson, M, Hausenloy, D, Sheikh, A, Hawkins, P, Moon, J

    Published 2013
    “…Conclusions: Bolus only, T1 mapping-derived ECV measurement is sufficient for ECV measurement across a range of cardiac diseases, and this approach is histologically validated in AS. …”
    Journal article